Navigation Links
Accuray Incorporated to Present at 20th Annual Piper Jaffray Health Care Conference
Date:11/24/2008

SUNNYVALE, Calif., Nov. 24 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that its management is scheduled to present at the 20th Annual Piper Jaffray Health Care Conference in New York City, on Wednesday, December 3, 2008 at 9:00 a.m. EST (6:00 a.m. PST).

A live webcast of the presentation will be available online from the investor relations page of the Company's Web site at http://www.accuray.com. The webcast replay of the presentation will begin approximately one hour after the conclusion of the live presentation and will be available for approximately 30 days.

About the CyberKnife(R) Robotic Radiosurgery System

The CyberKnife Robotic Radiosurgery System is the world's only robotic radiosurgery system designed to treat tumors anywhere in the body non-invasively. Using continual image guidance technology and computer controlled robotic mobility, the CyberKnife System automatically tracks, detects and corrects for tumor and patient movement in real-time throughout the treatment. This enables the CyberKnife System to deliver high-dose radiation with pinpoint precision, which minimizes damage to surrounding healthy tissue and eliminates the need for invasive head or body stabilization frames.

About Accuray

Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is a global leader in the field of radiosurgery dedicated to providing an improved quality of life and a non-surgical treatment option for those diagnosed with cancer. Accuray develops and markets the CyberKnife Robotic Radiosurgery System, which extends the benefits of radiosurgery to include e
'/>"/>

SOURCE Accuray Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Accuray Receives Nasdaq Notification Related to the Late Filing of Form 10-Q
2. Accuray Incorporated Ranked Fifth in Deloittes Technology Fast 50 Program for Silicon Valley Scientific/Medical Equipment, and Biotechnology Companies
3. Accuray Incorporated to Speak at Oppenheimer Healthcare Conference
4. Accuray Incorporated to Report First Quarter Fiscal Year 2009 Financial Results
5. Accuray Incorporated Announces Resignation of Chief Financial Officer
6. Accuray Incorporated to Report Fourth Quarter and Fiscal Year 2008 Financial Results
7. Accuray Incorporateds CEO to Speak at Jefferies Second Annual Healthcare Conference
8. Accuray Incorporateds CEO to Present at Morgan Stanley 2008 Global Healthcare Unplugged Conference
9. Accuray Incorporated to Report Third Quarter Fiscal Year 2008 Financial Results
10. Accurays CFO to Present at B. Riley & Company Ninth Annual Investor Conference
11. Accurays CyberKnife System Receives 2008 North American Medical Devices Product of the Year Award From Frost & Sullivan

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...RNewswire/ -- Davis Bregman , a pain management...esidents of Manhattan in New York City. Patients ...g the office at 212-918-1629 or sending an email f...g able to see the doctor in the less stressful hom...y of seeing most patients. The service will be fe...
(Date:11/9/2009)...women treated for breast cancer are at higher risk...Published in the December 15, 2009 issue of Cance... Society, the study,s results indicate that breast...om additional therapies following surgery, such as...en with dense breast tissue are at increased risk ...
(Date:11/8/2009)... Today, the nation Mayor...assing, the Affordable Health Care for America Act...t step in reforming America,s healthcare system. ,...l Meeting in Providence (RI), mayors from across t...form principles of reducing the long-term growth o...
(Date:11/8/2009)...on would strengthen Medicare, improve coverage for...-USNewswire/ -- SUMMARY: Yesterday the United St...th care reform legislation that would strengthen M...rance companies that prices millions of Americans ...ordable Health Care for America Act (H.R. 3962) ma...
(Date:11/8/2009)... Passage of Health Care Reform Bill ,, Critic...coverage for all Americans ,, HARRISBURG, Penn...RY: Last night the United States House of Represe...ation that would strengthen Medicare for seniors a...prices millions of Americans out of affordable hea...
Breaking Medicine News(10 mins):Health News:Davis Bregman MD Now Offering House Calls in Manhattan 2Health News:Breast density associated with increased risk of cancer recurrence 2Health News:The Nation's Mayors Commend House Passage of Health Reform Bill 2Health News:AARP NY Praises House Passage of Health Care Reform Bill 2Health News:AARP NY Praises House Passage of Health Care Reform Bill 3Health News:AARP NY Praises House Passage of Health Care Reform Bill 4Health News:AARP Pennsylvania Key Vote News Alert 2Health News:AARP Pennsylvania Key Vote News Alert 3Health News:AARP Pennsylvania Key Vote News Alert 4
... 10 BeaconEquity.com announces the,availability o...., Investors can view all of the daily trading no....com/m , Today,s TraderNotes include: Lantis Lase...n Board: OISI), Alcon Inc.,(NYSE: ACL ), Luminex ...
... science academies for the G8+5 countries issued s...on two pressing global challenges. To mitigate an...ansition to being "low-carbon societies," a shift ... sources. Meeting global health challenges, such ...
...laz Therapy described as ,Advance Against Acne, P...,Isolaz(TM) painless acne therapy has been feature...eport, a leading national weekly news magazine.,Th...treat comedonal and pustular acne, in addition to ...
...rom an Expert in Making Fatherhood Happen, ATLANT...ics data indicate that Georgia had 149,919 new bab...ailable. That means, obviously, not only,were ther...said,fertility expert Dr. Mark Perloe of Georgia R...
...K: Over 95% of patients with testicular cancer ar...new problem for cancer survivors, the medical prof...ill tell Teenage Cancer Trust,s Fifth Internationa...or of program development and director of the germ...
...th irritable bowel syndrome have a higher than usu...ng to a new study published tomorrow (Wednesday 11... Gut , could lead to new therapies for the estima...ain, bloating, and bowel problems such as constipa...
Other Medicine News:Health News:BeaconEquity.com Issues TraderNotes on Medical Instruments and Supplies Stocks: LLSR, EMITF, BLTI, OISI, ACL, LMNX, MELA, PMII 2Health News:BeaconEquity.com Issues TraderNotes on Medical Instruments and Supplies Stocks: LLSR, EMITF, BLTI, OISI, ACL, LMNX, MELA, PMII 3Health News:Breakthrough Isolaz(TM) Acne Therapy Featured in U.S. News & World Report: 2Health News:Thinking About Being a Father? 2Health News:Experts highlight gaps in knowledge on caring for survivors of teenage and young adult cancers 2Health News:Experts highlight gaps in knowledge on caring for survivors of teenage and young adult cancers 3Health News:Experts highlight gaps in knowledge on caring for survivors of teenage and young adult cancers 4Health News:Common bowel problem linked to chili pepper pain receptor 2
(Date:11/6/2009)...e-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin B...ta-based, biopharmaceutical company developing hum...munodeficiency Virus) and other infectious agents,...results and provided an operational update. ,, ...ve Officer commented, "We are pleased with our pro...
(Date:11/6/2009)...e-FirstCall/ -- Caraco Pharmaceutical Laboratories...romethamine ophthalmic solution, 0.5% following a ...ation (FDA) for Sun Pharma,s Abbreviated New Drug ...mic solution on the first day following patent exp...ally equivalent to Acular® Ophthalmic Solutio...
(Date:11/6/2009)...ewswire/ -- , - Trial Will Compare NXL103...nt of Multi-Resistant Staphylococcus Aureus (MRSA)...aceutical company focused on the discovery and,dev... the significant global,problem of microbial resis...,antibacterial NXL103 (flopristin/linopristin), ha...
Breaking Medicine Technology:GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 2GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 3GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 4GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 5GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 6GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 7GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 8Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 3Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 4New Complimentary Wallet Card to Tackle Concussions Head On 58903 1New Complimentary Wallet Card to Tackle Concussions Head On 58903 2CTIA West Wireless Health Institute Qualcomm and CommNexus San Diego Present 3A San Diego The Nations Hub for Wireless Healthcare 58900 1CTIA West Wireless Health Institute Qualcomm and CommNexus San Diego Present 3A San Diego The Nations Hub for Wireless Healthcare 58900 2Verenium Announces Proposed Public Offering of Common Stock 14359 1Verenium Announces Proposed Public Offering of Common Stock 14359 2Verenium Announces Proposed Public Offering of Common Stock 14359 3
...t of TRILOGY ACS clinical trial to study Prasug...atients, TOKYO and INDIANAPOLIS, June 23 Daiichi... and Company (NYSE: LLY ),said that the U.S. Food...view period for the prasugrel new drug application...during the review period. This three,month extensi...
...n who would like to have,children but who have not...their lives, the door to a new option has opened w... technique known as,vitrification, a quick freezin.... In what researchers are calling the most exhaust...ed that children born after the freezing,procedure...
Other Medicine Technology:FDA Extends Review Period for Daiichi Sankyo, Lilly Investigative Antiplatelet Drug, Prasugrel 2FDA Extends Review Period for Daiichi Sankyo, Lilly Investigative Antiplatelet Drug, Prasugrel 3FDA Extends Review Period for Daiichi Sankyo, Lilly Investigative Antiplatelet Drug, Prasugrel 4New Research Just Released: Women Can Now Safely Postpone Motherhood Until Time Is Right 2
Shandon Pathcentre Netmon Service
Shandon Excelsior Tissue Processor
Shandon Gross-Star Grossing Workbench
Shandon Hyperclean 20 Fume Handling Station
Medicine Products: